Literature DB >> 22732258

Highly loaded hemoglobin spheres as promising artificial oxygen carriers.

Li Duan1, Xuehai Yan, Anhe Wang, Yi Jia, Junbai Li.   

Abstract

Seeking safe and effective artificial blood substitutes based on hemoglobin (Hb) as oxygen carriers is an important topic. A significant challenge is to enhance the loading content of Hb in a well-defined structure. Here we report a facile and controllable avenue to fabricate Hb spheres with a high loading content by templating decomposable porous CaCO(3) particles in collaboration with covalent layer-by-layer assembly technique. The surface of the Hb spheres was further chemically modified by biocompatible polyethylene glycol to protect and stabilize the system. Multiple characterization techniques were employed to reveal the loading and density of Hb in an individual CaCO(3) particle. The results demonstrate that the strategy developed in this work is effective and flexible for construction of the highly loaded Hb spheres. More importantly, such Hb spheres retain their carrying-releasing oxygen function. It may thus have great potential to develop Hb spheres with highly loaded content as realistic artificial blood substitutes in the future.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22732258     DOI: 10.1021/nn301735u

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  12 in total

1.  2017 Military Supplement: Hemoglobin-based Oxygen Carriers: Current State-of-the-Art and Novel Molecules.

Authors:  Anirban Sen Gupta
Journal:  Shock       Date:  2017-09-29       Impact factor: 3.454

Review 2.  Bio-inspired nanomedicine strategies for artificial blood components.

Authors:  Anirban Sen Gupta
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2017-03-15

Review 3.  Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy.

Authors:  Zijian Zhou; Jibin Song; Liming Nie; Xiaoyuan Chen
Journal:  Chem Soc Rev       Date:  2016-11-21       Impact factor: 54.564

4.  A Novel Artificial Hemoglobin Carrier Based on Heulandite-Calcium Mesoporous Aluminosilicate Particles.

Authors:  Dino Jordanoski; Damjana Drobne; Neža Repar; Iztok Dogsa; Polona Mrak; Romana Cerc-Korošec; Andrijana Sever Škapin; Peter Nadrah; Natasa Poklar Ulrih
Journal:  Int J Mol Sci       Date:  2022-07-05       Impact factor: 6.208

5.  Self-Monitoring Artificial Red Cells with Sufficient Oxygen Supply for Enhanced Photodynamic Therapy.

Authors:  Zhenyu Luo; Mingbin Zheng; Pengfei Zhao; Ze Chen; Fungming Siu; Ping Gong; Guanhui Gao; Zonghai Sheng; Cuifang Zheng; Yifan Ma; Lintao Cai
Journal:  Sci Rep       Date:  2016-03-18       Impact factor: 4.379

6.  Direct comparison of oligochaete erythrocruorins as potential blood substitutes.

Authors:  Devon Zimmerman; Matthew DiIusto; Jack Dienes; Osheiza Abdulmalik; Jacob J Elmer
Journal:  Bioeng Transl Med       Date:  2017-07-19

7.  Tumor-targeted hybrid protein oxygen carrier to simultaneously enhance hypoxia-dampened chemotherapy and photodynamic therapy at a single dose.

Authors:  Zhenyu Luo; Hao Tian; Lanlan Liu; Zhikuan Chen; Ruijing Liang; Ze Chen; Zhihao Wu; Aiqing Ma; Mingbin Zheng; Lintao Cai
Journal:  Theranostics       Date:  2018-06-07       Impact factor: 11.556

Review 8.  Recent advances in innovative strategies for enhanced cancer photodynamic therapy.

Authors:  Tingting Hu; Zhengdi Wang; Weicheng Shen; Ruizheng Liang; Dan Yan; Min Wei
Journal:  Theranostics       Date:  2021-01-15       Impact factor: 11.556

Review 9.  Evolution of Nanoparticle-Mediated Photodynamic Therapy: From Superficial to Deep-Seated Cancers.

Authors:  Maharajan Sivasubramanian; Yao Chen Chuang; Leu-Wei Lo
Journal:  Molecules       Date:  2019-01-31       Impact factor: 4.411

10.  Hemoglobin-mediated biomimetic synthesis of paramagnetic O2-evolving theranostic nanoprobes for MR imaging-guided enhanced photodynamic therapy of tumor.

Authors:  Xiudong Shi; Weitao Yang; Qiong Ma; Yang Lu; Yan Xu; Kexin Bian; Fengjun Liu; Chunzi Shi; Han Wang; Yuxin Shi; Bingbo Zhang
Journal:  Theranostics       Date:  2020-09-19       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.